Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck : (Record no. 81263)

000 -LEADER
fixed length control field 02322pab a2200397 454500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 161010b2016 xxu||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Ghosh-Laskar S
245 ## - TITLE STATEMENT
Title Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck :
Remainder of title Results of a prospective randomized trial
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York NY
Name of publisher, distributor, etc. John Wiley And Sons
Date of publication, distribution, etc. 2016
300 ## - PHYSICAL DESCRIPTION
Extent 202-207
490 ## - SERIES STATEMENT
Series statement Vol. 2 ,no. 38
520 ## - SUMMARY, ETC.
Summary, etc. BACKGROUND: The purpose of this study was to report the results of a phase III, 3-arm, randomized trial comparing conventional radiotherapy (RT) to concurrent chemoradiotherapy (CRT) and accelerated RT in advanced head and neck squamous cell carcinoma (HNSCC). METHODS: One hundred eighty-six of 750 planned patients were randomized to receive one of the following treatment plans: RT (66-70 Gy/2 Gy fraction/5 fractions weekly; CRT of weekly cisplatin (30 mg/m(2) ) with the same RT dose; or accelerated RT alone of 66 to 70 Gy/2 Gy fraction/6 fractions weekly were available for analysis. The primary endpoint was locoregional control at 5 years. RESULTS: The mean follow-up was 54 months. Among the 3 arms, CRT showed superior locoregional control (49%; p = .049). RT had lower grade ≥3 mucositis and late toxicity. CONCLUSION: CRT is associated with significantly better locoregional control as compared to RT and accelerated RT with higher but acceptable acute and late toxicities. © 2015 Wiley Periodicals, Inc. Head Neck 38: 202-207, 2016.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Location of event radiotherapy (RT)
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Location of event head and neck squamous cell carcinoma (HNSCC)
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Location of event Cisplatin
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Location of event chemoradiotherapy (CRT)
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Location of event accelerated radiotherapy
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Agarwal J
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name D'Cruz A
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Chaturvedi P
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Pai P
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Chaukar D
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Sengar M
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Murthy V
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Budrukkar A
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Gupta T
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Kalyani N
773 ## - HOST ITEM ENTRY
Main entry heading Head & Neck
Place, publisher, and date of publication New York NY : John Wiley And Sons
International Standard Serial Number 1097-0347
Related parts Vol.38, no.2, p.202-207
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://10.3.0.2/mm01/Articles/AR17804.pdf
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
h TMH
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
b TMC
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a Radiation Oncology
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
c 25224814
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
f International
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
e journalArticle
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
        Tata Memorial Hospital Tata Memorial Hospital 2017-01-19 AR17804 2017-01-19 2017-01-19 Articles

Powered by Koha